3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| S14506 | 化合物 T28637 | 135722-25-7 |
| RS-1 | 4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 | 312756-74-4 |
| CPFX1302 | [CPFX1302] | |
| IITZ-01 | IITZ-01 | 1807988-47-1 |
| S 14506HCl | 化合物 T23285 | 286369-38-8 |
| TQB3804 | 5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 | 2267329-76-8 |
| MAC-545496 | MAC-545496 | 838810-96-1 |
| Eclitasertib | ECLITASERTIB | 2125450-76-0 |
| WM-3835 | 化合物WM-3835 | 2229025-70-9 |
| MCC7840 sodium | MCC7840 SODIUM | 2380032-29-9 |
| BI-4020 | RESATORVID | 2664214-60-0 |
| N-BIOTINYL-3,6,9-TRIOXAUNDECANE-1,11-DIAMINE | N-生物素-3,6,9-三氧杂十一烷-1,11-二胺 | 359860-27-8 |
| PIK-294 | PIK-294 | 900185-02-6 |
| ISX9 | ISX 9 | 832115-62-5 |
| GNF 179 | GNF179 | 1261114-01-5 |
| GPR39-C3 | CS-2374 | 1621175-65-2 |
| BGB-290 | 帕米帕利 | 1446261-44-4 |
| ZL0420 | 化合物ZL0420 | 2229039-45-4 |
| HS1371 | HS1371 | 2158197-70-5 |
| BAY61-3606 | 2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺 | 732983-37-8 |
| JH-X-119-01 | 2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- | 2227368-54-7 |
| KB-0742HCl | KB-0742 HCL | 2416873-83-9 |
| CID755673 | 2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one | 521937-07-5 |
| Tezacaftor | VX-661 | 1152311-62-0 |
| AR7 | CS-2649 | 80306-38-3 |
| SP2509 | SP2509 | 1423715-09-6 |
| BIOTIN 5-BROMOPENTYLAMIDE | 生物素5-溴戊基酰胺 | 1217605-72-5 |
| XY1 | N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1624117-53-8 |
| M2I-1 | 312271-03-7 | 312271-03-7 |
| C188-9 | 432001-19-9 | 432001-19-9 |
| DC661 | DC661 | 1872387-43-3 |
| TH5487 | TH 5487 | 2304947-71-3 |
| YC-6 | 雄甾-3,5,6??三醇 | 4725-51-3 |
| 3-Cyano-7-ethoxycoumarin | 3-氰基-7-乙氧基香豆素 | 117620-77-6 |
| (+)-BIOTIN-EPSILON-AMINOCAPROIC ACID | N-(+)-生物素酰基-6-氨基己酸 | 72040-64-3 |
| DGY-06-116 | DGY-06-116 | 2556836-50-9 |
| HG-9-91-01 | N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲 | 1456858-58-4 |
| MPI-0479605 | N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 | 1246529-32-7 |
| LXS-196 | LXS-196 | 1874276-76-2 |
| ACT-703328 | ACT-703328 | |
| IM156 | IM156 | 1422365-93-2 |
| AurorakinaseinhibitorIII | AURORA KINASE INHIBITOR III | 879127-16-9 |
| BMS-3 | BMS-3 | 1338247-30-5 |
| BD1063HCl | BD1063(盐酸盐) | 206996-13-6 |
| RX-3117 int | RX-3117中间体 | 805245-41-4 |
| (2R,3R,4R,5R,6R)-5-acetamido-2-(acetoxymethyl)-6-azidotetrahydro-2H-pyran-3,4-diyl diacetate | Azido 2-AcetaMido-2-deoxy-3,4,6-tri-O-acetyl-β-D-galactopyranosyl | 39541-20-3 |
| JH-II-127 | JH-II-127 | 1700693-08-8 |
| BIOTINAMIDOCAPROYL HYDRAZIDE | 生物素酰胺基己酸肼 | 109276-34-8 |
| OICR-9429 | OICR-9429 | 1801787-56-3 |
| Bohemine | BOHEMINE | 189232-42-6 |
| BO-264 | BO-264 | 2408648-20-2 |
| biotinylamidoethylacetamide | 乙二胺生物素 | 111790-37-5 |
| PCI34051 | N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺 | 950762-95-5 |
| ML204 | 4-METHYL-2-(1-PIPERIDINYL)-QUINOLINE | 5465-86-1 |
| PF-06447475 | PF-06447475 | 1527473-33-1 |
| PF-06454589 | CS-2879 | 1527473-30-8 |
| WZB117 | WZB-117 | 1223397-11-2 |
| CDKI-73 | CS-2259 | 1421693-22-2 |
| TA01 | TA 01 | 1784751-18-3 |
| reversine | REVERSINE | 656820-32-5 |
| SB202190 | 4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑 | 152121-30-7 |
| ZT-12-037-01 | ZT-12-037-01 | 2328073-61-4 |
| JAK-IN-5 | JAK-IN-5 | 2096999-92-5 |
| NS-3-008（HCl） | NS-3-008（HCl） | 1172854-54-4 |
| JNJ-7706621 | JNJ-7706621 | 443797-96-4 |
| GSK369796HCl | GSK369796 | 1010411-21-8 |
| (2R,3R,4R,5R,6R)-5-acetamido-2-(acetoxymethyl)-6-aminotetrahydro-2H-pyran-3,4-diyl diacetate | 2-(AcetylaMino)-2-deoxy-β-D-galactopyranosylaMine 3,4,6-Triacetate | 39541-22-5 |
| Methylpiperidino pyrazole | 1,3-BIS(4-HYDROXYPHENYL)-4-METHYL-5-[4-(2-PIPERIDINYLETHOXY)PHENOL]-1H-PYRAZOLE DIHYDROCHLORIDE | 289726-02-9 |
| NDI-091143 | NDI-091143 | 2375840-87-0 |
| EN4 | 化合物EN4 MYC INHIBITOR | 1197824-15-9 |
| BMS-5 | BMS-5 | 1338247-35-0 |
| MSX-122 | MSX 122 | 897657-95-3 |
| Lemborexant | 莱博雷生 | 1369764-02-2 |
| Stattic | Stattic | 19983-44-9 |
| BMS817378 | [3-[[4-((2-氨基-3-氯吡啶-4-基)氧基)-3-氟苯基]氨基甲酰基]-5-(4-氟苯基)-4-氧代-4H-吡啶-1-基]甲基磷酸二氢酯 | 1174161-69-3 |
| PQR309Bimiralisib | PI3K/MTOR抑制剂 | 1225037-39-7 |
| SGC707 | N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1687736-54-4 |
| E6005 | E6005 | 947620-48-6 |
| LSP-249 | LSP-249 | 1801253-04-2 |
| BAY-8002 | 2-(2-氯-5-(苯基磺酰基)苯甲酰氨基)苯甲酸 | 724440-27-1 |
| ML-109 | ML-109 | 1186649-91-1 |
| Monastrol | CS-2432 | 254753-54-3 |
| HPI-4,HedgehogPathwayInhibitor | 4302803-72-1 | |
| NIBR189 | NIBR189 | 1599432-08-2 |
| TA02 | TA 02 | 1784751-19-4 |
| SF2523 | SF-2523 | 1174428-47-7 |
| Takinib | 1111556-37-6 | 1111556-37-6 |
| CPFX2090 | CPFX2090 | 1429439-25-7 |
| Dynarrestin | Dynarrestin | 2222768-84-3 |
| V-9302 | V-9302 | 1855871-76-9 |
| Enavogliflozin | D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- | 1415472-28-4 |
| 2-PMPA(NAALADaseinhibitor) | 2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID | 173039-10-6 |
| GDC-0214 | ||
| C75 | 反-4-羧基-5-辛基-3-甲基-丁内酯 | 191282-48-1 |
| (3-Azidopropyl)triphenylphosphoniuM BroMide | (3-Azidopropyl)triphenylphosphoniuM BroMide | 127611-39-6 |
| U104/NSC213841/MST104 | U-104 | 178606-66-1 |
| Ruzasvir | S 14506HCL | 1613081-64-3 |
| LIT-927 | LIT-927游离 | 2172879-52-4 |
| S(-)-RACLOPRIDE L-TARTRATE | 雷氯必利 | 84225-95-6 |
| GDC-0214 | IJAK-381 | 1831144-46-7 |
联系方式
